FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138766095> ?p ?o ?g. }

• W2138766095 endingPage "352" @default.
• W2138766095 startingPage "346" @default.
• W2138766095 abstract "Evaluate long-term safety and efficacy of etanercept treatment in patients with ankylosing spondylitis (AS).Patients with AS who previously participated in a randomised controlled trial (RCT) of etanercept were eligible to enroll in a 168-week open-label extension (OLE). Safety end points included rates of adverse events (AE), serious adverse events (SAE), infections, serious infections and death. Efficacy end points included Assessment in Ankylosing Spondylitis (ASAS20) response, ASAS 5/6 response and partial remission rates.A total of 257 of 277 patients (92%) enrolled in the OLE. After up to 192 weeks of treatment with etanercept, the most common AEs were injection site reactions, headaches and diarrhoea. The exposure-adjusted rate of SAEs was 0.08 per patient-year. The rate of infections was 1.1 per patient-year, and the rate for serious infections was 0.02 per patient-year. No deaths were reported. Of patients who received etanercept in both the RCT and OLE and were still in the trial, 71% were ASAS20 responders at week 96, and 81% were responders at week 192. ASAS 5/6 response rates were 61% at week 96 and 60% at week 144, and partial remission response rates were 41% at week 96 and 44% at week 192. Placebo patients who switched to etanercept in the OLE showed similar patterns of efficacy maintenance.Etanercept was well tolerated for up to 192 weeks in patients with AS, with no unexpected AEs or SAEs observed. No deaths were reported. Improvements in the signs and symptoms of AS were maintained for up to 192 weeks." @default.
• W2138766095 created "2016-06-24" @default.
• W2138766095 creator A5005609698 @default.
• W2138766095 creator A5010726887 @default.
• W2138766095 creator A5035193273 @default.
• W2138766095 creator A5035571112 @default.
• W2138766095 creator A5038121079 @default.
• W2138766095 creator A5039584752 @default.
• W2138766095 creator A5046261111 @default.
• W2138766095 creator A5069831361 @default.
• W2138766095 creator A5077099389 @default.
• W2138766095 creator A5082669130 @default.
• W2138766095 creator A5088051469 @default.
• W2138766095 date "2007-10-29" @default.
• W2138766095 modified "2023-10-01" @default.
• W2138766095 title "Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis" @default.
• W2138766095 cites W1820529965 @default.
• W2138766095 cites W1975137544 @default.
• W2138766095 cites W1990043465 @default.
• W2138766095 cites W1990305566 @default.
• W2138766095 cites W1995356102 @default.
• W2138766095 cites W1995963840 @default.
• W2138766095 cites W1999247995 @default.
• W2138766095 cites W2018410379 @default.
• W2138766095 cites W2027454708 @default.
• W2138766095 cites W2030187620 @default.
• W2138766095 cites W2034608764 @default.
• W2138766095 cites W2049358634 @default.
• W2138766095 cites W2055734184 @default.
• W2138766095 cites W2058674147 @default.
• W2138766095 cites W2074593320 @default.
• W2138766095 cites W2087193868 @default.
• W2138766095 cites W2107174064 @default.
• W2138766095 cites W2134122064 @default.
• W2138766095 cites W2141081169 @default.
• W2138766095 cites W2157270348 @default.
• W2138766095 cites W2165062595 @default.
• W2138766095 cites W2442688958 @default.
• W2138766095 cites W2473390031 @default.
• W2138766095 cites W3149502507 @default.
• W2138766095 cites W1788772880 @default.
• W2138766095 cites W2118359937 @default.
• W2138766095 doi "https://doi.org/10.1136/ard.2007.078139" @default.
• W2138766095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17967833" @default.
• W2138766095 hasPublicationYear "2007" @default.
• W2138766095 type Work @default.
• W2138766095 sameAs 2138766095 @default.
• W2138766095 citedByCount "136" @default.
• W2138766095 countsByYear W21387660952012 @default.
• W2138766095 countsByYear W21387660952013 @default.
• W2138766095 countsByYear W21387660952014 @default.
• W2138766095 countsByYear W21387660952015 @default.
• W2138766095 countsByYear W21387660952016 @default.
• W2138766095 countsByYear W21387660952017 @default.
• W2138766095 countsByYear W21387660952018 @default.
• W2138766095 countsByYear W21387660952019 @default.
• W2138766095 countsByYear W21387660952020 @default.
• W2138766095 countsByYear W21387660952021 @default.
• W2138766095 countsByYear W21387660952022 @default.
• W2138766095 countsByYear W21387660952023 @default.
• W2138766095 crossrefType "journal-article" @default.
• W2138766095 hasAuthorship W2138766095A5005609698 @default.
• W2138766095 hasAuthorship W2138766095A5010726887 @default.
• W2138766095 hasAuthorship W2138766095A5035193273 @default.
• W2138766095 hasAuthorship W2138766095A5035571112 @default.
• W2138766095 hasAuthorship W2138766095A5038121079 @default.
• W2138766095 hasAuthorship W2138766095A5039584752 @default.
• W2138766095 hasAuthorship W2138766095A5046261111 @default.
• W2138766095 hasAuthorship W2138766095A5069831361 @default.
• W2138766095 hasAuthorship W2138766095A5077099389 @default.
• W2138766095 hasAuthorship W2138766095A5082669130 @default.
• W2138766095 hasAuthorship W2138766095A5088051469 @default.
• W2138766095 hasBestOaLocation W21387660951 @default.
• W2138766095 hasConcept C126322002 @default.
• W2138766095 hasConcept C141071460 @default.
• W2138766095 hasConcept C142724271 @default.
• W2138766095 hasConcept C168563851 @default.
• W2138766095 hasConcept C197934379 @default.
• W2138766095 hasConcept C204787440 @default.
• W2138766095 hasConcept C27081682 @default.
• W2138766095 hasConcept C2777226972 @default.
• W2138766095 hasConcept C2777402515 @default.
• W2138766095 hasConcept C2777575956 @default.
• W2138766095 hasConcept C2779650986 @default.
• W2138766095 hasConcept C71924100 @default.
• W2138766095 hasConceptScore W2138766095C126322002 @default.
• W2138766095 hasConceptScore W2138766095C141071460 @default.
• W2138766095 hasConceptScore W2138766095C142724271 @default.
• W2138766095 hasConceptScore W2138766095C168563851 @default.
• W2138766095 hasConceptScore W2138766095C197934379 @default.
• W2138766095 hasConceptScore W2138766095C204787440 @default.
• W2138766095 hasConceptScore W2138766095C27081682 @default.
• W2138766095 hasConceptScore W2138766095C2777226972 @default.
• W2138766095 hasConceptScore W2138766095C2777402515 @default.
• W2138766095 hasConceptScore W2138766095C2777575956 @default.
• W2138766095 hasConceptScore W2138766095C2779650986 @default.
• W2138766095 hasConceptScore W2138766095C71924100 @default.
• W2138766095 hasIssue "3" @default.

• next